Medcolcanna Organics Inc

What Medcolcanna Organics Inc does

Medcolcanna Organics Inc. is a Canadian-incorporated, CSE-listed (ticker: MCCN) cannabis company that operates a vertically integrated cultivation and production platform out of Colombia, with headquarters near Bogotá. The company cultivates cannabis and processes it into pharmaceutical-grade flowers, extracts, distillates, isolates, and active pharmaceutical ingredients (APIs), as well as finished consumer products including dermocosmetics, food supplements, and veterinary products. Its technology foundation comprises modern indoor GMP EU-standard facilities, a proprietary genetics programme for exotic Colombian strains (with THC content consistently in the 22.8%-23.1% range), and cell tissue culture laboratories for disease-free propagation. Named flower SKUs include MCCN No. 2 Skywalker, No. 5 Lemon Sour Diesel, and No. 8 OG Kush, sold under the Encanto sub-brand.

The company monetizes through direct B2B relationships with major pharmaceutical wholesalers and pharmacy chains in target international markets — Germany, UK, Poland, and Australia — as well as supplying APIs and intermediates to pharmaceutical manufacturers and consumer-product companies. Pricing is quote-based and not publicly disclosed. It also offers contract production and extraction services to local and international cannabis-industry participants. A strategic R&D partnership with the University of Groningen is funding clinical trials of 12 proprietary formulations targeting epilepsy, chronic pain, and chemotherapy-induced nausea.

Operationally, Medcolcanna is a micro-cap that has funded itself via two small bridge loans (USD $100K in March 2023 and USD $500K in June 2023) from a significant shareholder at 12% interest, and disclosed no revenue. A February 2025 shareholder meeting was convened explicitly to counter perceptions that the company had ceased operations, indicating material operational fragility. The company is led by CEO and founder Felipe de la Vega (former founder/CEO of Trenaco Holding Corporation, which reached USD $800M in revenue) and COO Nicolás Rodríguez, an agricultural engineer with prior agro-industry scaling experience.

Name

Medcolcanna Organics Inc

Legal name

Medcolcanna Organics Inc.

Website

https://medcolcanna.com

Company type

Public

Founded year

2010

Operating status

Operating

Headcount range

51–100 employees

Short description

Medcolcanna Organics Inc. is a Canadian-incorporated, CSE-listed vertically integrated cannabis company operating from Colombia that cultivates and processes pharmaceutical-grade cannabis flowers, extracts, APIs, and consumer products for export to wholesalers and pharmacies in Germany, UK, Poland, and Australia.

Ownership category

akta.pro rank

Headquarters

HQ city

Bogotá

HQ country

Colombia

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Cannabis Flower Exports: Production and export of pharmaceutical-grade THC cannabis flowers to high-value international markets including Germany, UK, Poland, and Australia
2. Cannabis Extracts, Distillates & Isolates: Production of cannabis derivatives including extracts, distillates, and isolates for pharmaceutical, nutraceutical, and cosmetic applications
3. Active Pharmaceutical Ingredients (API): Pharmaceutical-grade cannabis APIs for use in medicinal product manufacturing
4. Dermocosmetics & Consumer Products: Finished consumer products including dermocosmetics, food supplements, and veterinary products derived from cannabis
5. Production & Extraction Services: Contract production and extraction services for international and local industries supporting the cannabis industry's development

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Medcolcanna Organics is a vertically integrated cannabis company that cultivates cannabis in Colombia and transforms it into high-quality raw materials, commodities, and finished cannabis products for the global market. Its portfolio includes pharmaceutical-grade THC cannabis flowers, extracts, distillates, isolates, active pharmaceutical ingredients (APIs), and finished products such as nutraceuticals, dermocosmetics, and medicinal cannabis products supplied to international wholesalers and pharmacies.

Product overview

Medcolcanna Organics is a vertically integrated cannabis company operating from Colombia that cultivates cannabis and transforms it into high-quality raw materials, commodities, and finished cannabis products. The product portfolio includes multiple product lines: (1) Cannabis flower strains under the MCCN product line including MCCN No. 5 Lemon Sour Diesel (~23.0% THC), MCCN No. 2 Skywalker (~22.8% THC), and MCCN No. 8 OG Kush (~23.1% THC), all non-irradiated and produced in Colombia; (2) Intermediate products including cannabis extracts, distillates, isolates, and Active Pharmaceutical Ingredients (API) for pharmaceutical applications; (3) Finished consumer products including dermocosmetics, pharmaceutical products, food supplements, and veterinary products; (4) The Encanto sub-brand focused on Colombian medical cannabis flowers. The company leverages Colombia's agricultural expertise and climate advantages to serve high-value markets in Germany, UK, Poland, and Australia.

Differentiator

Problem solved

Functional benefit

Brands

• Encanto: A brand of Medcolcanna Organics (MCCN) that brings people closer to the therapeutic potential of cannabis with easily accessible Colombian flowers. The approach is based on cutting-edge technology, sustainable practices, and rigorous scientific research.

Products and services

• MCCN No. 2 Skywalker (Cannabis Flower Strain) A hybrid cannabis flower strain with approximately 22.8% THC and <1.0% CBD content, non-irradiated and produced in Colombia. Contains terpenes including limonene, beta-caryophyllene, and myrcene. Supplied to international pharmaceutical wholesalers and pharmacies.
• MCCN No. 5 Lemon Sour Diesel (Cannabis Flower Strain) A hybrid cannabis flower strain with approximately 23.0% THC and <1.0% CBD content, non-irradiated and produced in Colombia. Supplied to international pharmaceutical wholesalers and pharmacies.
• MCCN No. 8 OG Kush (Cannabis Flower Strain) A hybrid cannabis flower strain with approximately 23.1% THC and <1.0% CBD content, non-irradiated and produced in Colombia. Supplied to international pharmaceutical wholesalers and pharmacies.
• Cannabis Extracts, Distillates, and Isolates Cannabis derivatives including extracts, distillates, and isolates produced through pharmaceutical processes for use in pharmaceutical, nutraceutical, and cosmetic applications.
• Active Pharmaceutical Ingredients (API) Pharmaceutical-grade cannabis-derived active pharmaceutical ingredients for use in medicinal product formulations by pharmaceutical manufacturers.
• Dermocosmetics Line Cannabis-based dermocosmetic products for topical applications, derived from the company's cannabis extraction processes.
• Pharmaceutical Products Medicinal cannabis products manufactured under pharmaceutical-grade processes for patient treatments, developed in collaboration with clinical research partners.
• Food Supplements Cannabis-based nutritional supplements for health and wellness applications, produced from the company's cannabis derivatives.
• Veterinary Products Cannabis-derived products formulated for animal health applications, leveraging the company's cannabis extraction capabilities.
• Encanto Sub-brand Cannabis Flowers A sub-brand of Medcolcanna Organics focused on Colombian medical cannabis flowers, leveraging cutting-edge technology, sustainable practices, and rigorous scientific research to bring patients therapeutic cannabis products.
• GMP EU Flowers High-quality cannabis flowers produced under Good Manufacturing Practice (GMP) EU standards, featuring hybrid genetics and proprietary strain varieties for international export.
• Production & Extraction Services Contract production and extraction services for international and local industries, supporting the cannabis industry's development through collaborative and partnership approaches.

Quantifiable outcome

• THC content ranges from 22.8% to 23.1% across product strains
• +1 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• University of GroningencoreStrategic or Co-development PartnerMedcolcanna collaborates with the University of Groningen to clinically trial 12 specific formulations for 12 medical conditions that have been scientifically validated as being treatable with cannabis. This partnership supports clinical validation of the company's proprietary cannabis formulations and product development for conditions including epilepsy, chronic pain, and chemotherapy-induced nausea and vomiting.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Cresco Labs: US multi-state cannabis operator with international ambitions and product formulation expertise. Adjacent comparable in terms of finished product development (dermocosmetics, supplements) targeting similar wholesale and consumer channels.
• OrganiGram Holdings: Canadian cannabis producer with international medical distribution in Germany and other EU markets. Comparable wholesale/government-channel strategy and pharmaceutical-grade positioning.
• Aurora Cannabis: Large Canadian cannabis producer with global medical cannabis operations across Europe and Australia. Represents a broader incumbent competitor with substantially greater capital, established international distribution, and similar target-market overlap.
• Canopy Growth: Canadian-headquartered global cannabis company with international medical cannabis operations. Broad incumbent competitor in pharmaceutical-grade flower and APIs across multiple jurisdictions overlapping Medcolcanna's target markets.
• Tilray Brands: Global cannabis and CPG company with established EU and Australian medical cannabis operations. A larger incumbent serving overlapping pharmaceutical and wholesale channels, providing a benchmark for scale Medcolcanna would need to reach.

Direct peers

• PharmaCielo: Colombian cannabis cultivator producing extracts and dried flower for international medical markets. Direct competitor leveraging the same Colombian agricultural cost advantage and pursuing similar B2B pharmaceutical-grade distribution strategy.
• Clever Leaves Holdings: Colombian-headquartered, NASDAQ-listed cannabis cultivator producing GMP-certified cannabis flower, extracts, and APIs for international markets. Closest direct comparable to Medcolcanna given shared Colombian low-cost cultivation base, GMP EU focus, and pharmaceutical-grade B2B go-to-market.
• Flora Growth: Cannabis cultivator and manufacturer based in Colombia with operations spanning cultivation, processing, and consumer products. Comparable Colombian production base and vertically integrated model targeting international B2B and consumer channels.
• Avicanna: Canadian-listed biopharmaceutical company with cannabis cultivation in Colombia, focused on pharmaceutical-grade cannabinoid products for medical and cosmetic applications. Direct overlap with Medcolcanna's API, dermocosmetic, and clinical-validation approach.
• Khiron Life Sciences: Vertically integrated Colombian cannabis company with medical product focus across Latin America and Europe. Comparable operating geography (Colombia), vertical integration model, and medical/wholesale customer base targeting similar indications.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/medcolcanna

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medcolcanna Organics Inc